These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 25550940)
1. Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells. Chen C; Lu Y; Liu J; Li L; Zhao N; Lin B Int J Clin Exp Med; 2014; 7(11):4253-9. PubMed ID: 25550940 [TBL] [Abstract][Full Text] [Related]
2. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Bottomly D; Kyler SL; McWeeney SK; Yochum GS Nucleic Acids Res; 2010 Sep; 38(17):5735-45. PubMed ID: 20460455 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Hatzis P; van der Flier LG; van Driel MA; Guryev V; Nielsen F; Denissov S; Nijman IJ; Koster J; Santo EE; Welboren W; Versteeg R; Cuppen E; van de Wetering M; Clevers H; Stunnenberg HG Mol Cell Biol; 2008 Apr; 28(8):2732-44. PubMed ID: 18268006 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer. Lan F; Yue X; Han L; Shi Z; Yang Y; Pu P; Yao Z; Kang C Int J Oncol; 2012 Feb; 40(2):519-26. PubMed ID: 21956205 [TBL] [Abstract][Full Text] [Related]
5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
6. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505 [TBL] [Abstract][Full Text] [Related]
7. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer. Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929 [TBL] [Abstract][Full Text] [Related]
9. Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells. Hrckulak D; Janeckova L; Lanikova L; Kriz V; Horazna M; Babosova O; Vojtechova M; Galuskova K; Sloncova E; Korinek V Genes (Basel); 2018 Sep; 9(9):. PubMed ID: 30200414 [TBL] [Abstract][Full Text] [Related]
10. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2. Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781 [TBL] [Abstract][Full Text] [Related]
11. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
12. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling. Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424 [TBL] [Abstract][Full Text] [Related]
13. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis]. Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459 [TBL] [Abstract][Full Text] [Related]
15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
16. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Jung C; Kim RS; Zhang H; Lee SJ; Sheng H; Loehrer PJ; Gardner TA; Jeng MH; Kao C Br J Cancer; 2005 Jun; 92(12):2233-9. PubMed ID: 15928669 [TBL] [Abstract][Full Text] [Related]
17. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Yochum GS; Cleland R; Goodman RH Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287 [TBL] [Abstract][Full Text] [Related]
18. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426 [TBL] [Abstract][Full Text] [Related]
19. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression. Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]